David A. Siegel Pacific Biosciences Of California, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 122,200 shares of PACB stock, worth $213,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,200
Previous 144,400
15.37%
Holding current value
$213,850
Previous $541,000
69.13%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding PACB
# of Institutions
258Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$58.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$45.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$41.3 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$40.9 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$29.3 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $393M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...